Skip to article
Astra

Endocrinology

Thyroid Nodule

Evaluate thyroid nodules with clinical risk assessment, serum TSH, structured ultrasound risk stratification, and size-based FNA selection; then integrate Bethesda cytology, molecular testing when informative, patient fitness, and preferences to avoid both missed clinically important cancer and low-value biopsy or surgery.

Clinical question: How should clinicians select thyroid nodules for imaging, FNA, cytologic triage, and conservative follow-up?

First Visit

Identify nodules requiring expedited evaluation

Use clinical context to determine urgency before selecting imaging or biopsy.

Obtain a focused history for childhood or therapeutic neck irradiation, familial thyroid cancer syndromes, rapid structural change, and relevant comorbidity. Familial nonmedullary thyroid cancer is associated with multifocal disease, local invasion, nodal metastases, and local or regional recurrence more often than sporadic disease; this history should lower the threshold for expert ultrasound review and multidisciplinary planning. NatureFamilial thyroid cancer: a review | Modern Pathology

Avoid screening thyroid ultrasound in asymptomatic adults because detection of benign lesions and indolent malignancies can drive overdiagnosis and treatment morbidity without a demonstrated reduction in thyroid cancer mortality. Evaluate a palpable lesion, a clinically meaningful incidental imaging finding, or a patient with an established nodule instead. PubMed2023 European Thyroid Association Clinical Practice Guidelines for ...

In older adults and patients with substantial competing illness, make diagnostic intensity contingent on whether a result would alter management. A conservative approach can be reasonable for very-low-risk tumors, high operative risk, or limited life expectancy after shared decision-making. PubMedThyroid nodule evaluation and management in older adults: A review of practical considerations for clinical endocrinologists

Initial triage decisions for an identified thyroid nodule. PubMedThyroid nodule evaluation and management in older adults: A review of practical considerations for clinical endocrinologistsPubMed2023 European Thyroid Association Clinical Practice Guidelines for ...
Clinical settingImmediate next stepManagement implication
Asymptomatic adult without a known noduleDo not order screening thyroid ultrasound. PubMed2023 European Thyroid Association Clinical Practice Guidelines for ...Avoid detection-driven overdiagnosis and downstream procedures. PubMed2023 European Thyroid Association Clinical Practice Guidelines for ...
Known or incidentally detected thyroid noduleObtain thyroid-focused clinical assessment, serum TSH, and dedicated ultrasound risk stratification. PubMed2023 European Thyroid Association Clinical Practice Guidelines for ...Use functional status and ultrasound pattern to select scintigraphy, FNA, surveillance, or no further action. Oxford AcademicThe Treatment of Differentiated Thyroid Cancer in ChildrenPubMed2023 European Thyroid Association Clinical Practice Guidelines for ...
Older adult with major comorbidity or short life expectancyEstablish whether biopsy results would change treatment before FNA. PubMedThyroid nodule evaluation and management in older adults: A review of practical considerations for clinical endocrinologistsConservative management may be preferable for low-risk disease or high surgical risk. PubMedThyroid nodule evaluation and management in older adults: A review of practical considerations for clinical endocrinologists

Laboratory Branch

Use TSH to determine whether scintigraphy changes the pathway

Functional assessment precedes purely morphologic decision-making when TSH is low.

Measure serum TSH during initial evaluation. When TSH is suppressed, obtain radionuclide imaging to identify a hyperfunctioning nodule; this functional result redirects evaluation away from an ultrasound-only biopsy pathway and toward defining the cause of thyrotoxicosis. Oxford AcademicThe Treatment of Differentiated Thyroid Cancer in ChildrenPubMed2023 European Thyroid Association Clinical Practice Guidelines for ...

If free T4 is normal in a patient with biochemical concern for hyperthyroidism, measure free T3. Consider TSH-receptor antibodies when the clinical context requires clarification of hyperthyroid etiology; consider thyroid peroxidase antibodies when thyroiditis is clinically or sonographically suspected. PubMed2023 European Thyroid Association Clinical Practice Guidelines for ...

Routine calcitonin measurement is not uniformly recommended for every nodule. Consider it selectively when the clinical context raises concern for medullary thyroid carcinoma or when a result would alter preoperative planning. A case of a large, sonographically low-risk nodule illustrates that calcitonin and chromogranin A gene overexpression on molecular testing can identify medullary thyroid carcinoma despite Bethesda III cytology. PubMed2023 European Thyroid Association Clinical Practice Guidelines for ...facs[PDF] Unexpected Diagnosis of Sporadic Medullary Thyroid Carcinoma

Imaging and Biopsy

Select FNA by ultrasound risk pattern and size threshold

Use a formal ultrasound classification system rather than unstructured descriptive reporting.

Perform dedicated thyroid and cervical lymph-node ultrasound and assign a validated risk category. Both major guideline approaches support ultrasound to determine whether a nodule warrants ultrasound-guided fine-needle aspiration cytology rather than using palpation or size alone. WileyEvaluation and Management of Thyroid Nodules: A Joint Consensus ...Wolters KluwerPerformance of European Thyroid Imaging Reporting and Data... : Journal of Medical UltrasoundPubMed2023 European Thyroid Association Clinical Practice Guidelines for ...

In EU-TIRADS, high-risk category 5 requires at least one high-suspicion feature: irregular shape, irregular margins, microcalcifications, or marked hypoechogenicity. The 2023 ETA algorithm identifies FNA consideration for EU-TIRADS 5 nodules larger than 10 mm and for intermediate-risk EU-TIRADS 4 nodules larger than 15 mm; apply the reporting system’s complete recommendation set rather than transplanting thresholds across systems. PubMed2023 European Thyroid Association Clinical Practice Guidelines for ...

A spongiform appearance is strongly associated with benignity in the cited evidence, with 99.7% specificity and a 98.5% negative predictive value for malignancy. It does not eliminate the need to apply size-based biopsy criteria or reconsider the diagnosis when the lesion is large, symptomatic, growing, or otherwise clinically discordant. facs[PDF] Unexpected Diagnosis of Sporadic Medullary Thyroid Carcinoma

Do not add scintigraphy solely because a nodule falls below an ACR TI-RADS FNA threshold in an otherwise routine setting. In a retrospective cohort, cold scintigraphy prompted FNA in 66 subthreshold nodules, with Bethesda category III or higher cytology in 7 nodules (10.6%); most clinically significant cytology occurred in nodules that already met ACR TI-RADS FNA criteria. Wolters KluwerAdditional detection of Bethesda greater than or... : Nuclear Medicine Communications

Ultrasound findings and actions supported by the ETA/EU-TIRADS pathway. PubMed2023 European Thyroid Association Clinical Practice Guidelines for ...facs[PDF] Unexpected Diagnosis of Sporadic Medullary Thyroid Carcinoma
Ultrasound resultInterpretationAction
EU-TIRADS 5: irregular shape, irregular margins, microcalcifications, or marked hypoechogenicityHigh-risk pattern. PubMed2023 European Thyroid Association Clinical Practice Guidelines for ...Consider ultrasound-guided FNA when diameter is greater than 10 mm. PubMed2023 European Thyroid Association Clinical Practice Guidelines for ...
EU-TIRADS 4Intermediate-risk pattern. PubMed2023 European Thyroid Association Clinical Practice Guidelines for ...Consider ultrasound-guided FNA when diameter is greater than 15 mm. PubMed2023 European Thyroid Association Clinical Practice Guidelines for ...
Spongiform noduleVery high specificity and negative predictive value for benign disease in cited data. facs[PDF] Unexpected Diagnosis of Sporadic Medullary Thyroid CarcinomaApply guideline size criteria and clinical context; do not infer zero cancer risk. facs[PDF] Unexpected Diagnosis of Sporadic Medullary Thyroid Carcinoma
Nodule below ultrasound-system FNA thresholdMost clinically significant cytology in one cohort occurred in nodules already meeting ACR TI-RADS criteria. Wolters KluwerAdditional detection of Bethesda greater than or... : Nuclear Medicine CommunicationsDo not routinely use a cold scintigraphy result alone to override a subthreshold ACR TI-RADS recommendation. Wolters KluwerAdditional detection of Bethesda greater than or... : Nuclear Medicine Communications

Choosing a reporting system

ACR TI-RADS, ATA-pattern approaches, and EU-TIRADS use different category definitions and FNA thresholds. In older-adult data, ACR TI-RADS produced fewer unnecessary FNAs than ATA and Korean TI-RADS, but its lower sensitivity highlights the tradeoff between reducing procedures and potentially deferring diagnosis of some malignancies. PubMedThyroid nodule evaluation and management in older adults: A review of practical considerations for clinical endocrinologists

Do not alternate systems across serial examinations. Consistent reporting permits a reproducible biopsy decision and avoids apparent changes in risk caused only by switching classification rules. Comparative literature does not establish EU-TIRADS as superior to other TI-RADS systems. PubMedThe European Association of Nuclear Medicine (EANM)’s Response to the 2023 European Thyroid Association (ETA) clinical practice guidelines for thyroid nodule management and nuclear medicine: a deliberate oversight? - PMC

After FNA

Resolve indeterminate cytology with concordance, molecular testing, and treatment consequences

Bethesda III and IV results require risk refinement, not automatic thyroidectomy.

Interpret FNA cytology together with the pretest ultrasound risk category and the clinical scenario. Bethesda category III, atypia of undetermined significance, carries a cited malignancy risk of 6% to 18%; this range should not be treated as equivalent to a definitive malignant diagnosis. facs[PDF] Unexpected Diagnosis of Sporadic Medullary Thyroid Carcinoma

For Bethesda III or IV nodules, assess whether repeat sampling, molecular testing, active surveillance, or diagnostic surgery would change care. In a surgical retrospective cohort of 449 patients with Bethesda III or IV cytology, clinical characteristics and predictors were evaluated, reinforcing that these categories comprise a heterogeneous operative-risk group rather than a uniform indication for surgery. WileyClinical Outcomes of Patients With Bethesda III or IV Cytology on Fine Needle Aspiration of Thyroid Nodules—A Retrospective Study - Khan - 2025 - Endocrinology, Diabetes & Metabolism - Wiley Online Library

Use molecular testing only when its result will meaningfully alter the choice between surveillance and surgery or the scope of surgery. In a reported Bethesda III nodule, molecular evidence of calcitonin and chromogranin A gene overexpression conveyed a greater than 95% probability of medullary thyroid carcinoma and changed management despite absence of RET or RAS mutations. facs[PDF] Unexpected Diagnosis of Sporadic Medullary Thyroid Carcinoma

For Hürthle-cell–predominant aspirates, do not assume Hürthle cells independently establish malignancy. Hürthle-cell metaplasia may occur in chronic lymphocytic thyroiditis, and the presence of Hürthle cells does not increase malignancy risk in most Bethesda categories in cited literature; integrate nuclear atypia, ultrasound findings, and the overall Bethesda category. ScienceDirectA Retrospective Study of Clinicopathologic Outcomes of Nodules With Hürthle Cell Cytology and the Thyroid Nodule App (TNAPP) Ultrasound Recommendations - ScienceDirect

Decision framework after indeterminate thyroid FNA. WileyClinical Outcomes of Patients With Bethesda III or IV Cytology on Fine Needle Aspiration of Thyroid Nodules—A Retrospective Study - Khan - 2025 - Endocrinology, Diabetes & Metabolism - Wiley Online LibraryScienceDirectA Retrospective Study of Clinicopathologic Outcomes of Nodules With Hürthle Cell Cytology and the Thyroid Nodule App (TNAPP) Ultrasound Recommendations - ScienceDirectfacs[PDF] Unexpected Diagnosis of Sporadic Medullary Thyroid Carcinoma
Cytology scenarioKey discriminatorNext decision
Bethesda III (AUS)Cited malignancy risk is 6% to 18%; ultrasound and clinical concordance modify concern. facs[PDF] Unexpected Diagnosis of Sporadic Medullary Thyroid CarcinomaUse repeat sampling, molecular testing, surveillance, or surgery only after defining how the result changes management. WileyClinical Outcomes of Patients With Bethesda III or IV Cytology on Fine Needle Aspiration of Thyroid Nodules—A Retrospective Study - Khan - 2025 - Endocrinology, Diabetes & Metabolism - Wiley Online Libraryfacs[PDF] Unexpected Diagnosis of Sporadic Medullary Thyroid Carcinoma
Bethesda III with molecular profile strongly suggestive of medullary thyroid carcinomaCalcitonin and chromogranin A gene overexpression yielded a reported cancer probability greater than 95%. facs[PDF] Unexpected Diagnosis of Sporadic Medullary Thyroid CarcinomaEscalate to medullary thyroid carcinoma-specific preoperative planning. facs[PDF] Unexpected Diagnosis of Sporadic Medullary Thyroid Carcinoma
Bethesda IVIndeterminate category with heterogeneous surgical pathology outcomes. WileyClinical Outcomes of Patients With Bethesda III or IV Cytology on Fine Needle Aspiration of Thyroid Nodules—A Retrospective Study - Khan - 2025 - Endocrinology, Diabetes & Metabolism - Wiley Online LibraryIndividualize molecular testing and diagnostic surgery according to ultrasound risk, patient fitness, and preferences. WileyClinical Outcomes of Patients With Bethesda III or IV Cytology on Fine Needle Aspiration of Thyroid Nodules—A Retrospective Study - Khan - 2025 - Endocrinology, Diabetes & Metabolism - Wiley Online Library
Hürthle-cell–predominant aspirateHürthle cells alone do not establish increased malignancy risk in most Bethesda categories. ScienceDirectA Retrospective Study of Clinicopathologic Outcomes of Nodules With Hürthle Cell Cytology and the Thyroid Nodule App (TNAPP) Ultrasound Recommendations - ScienceDirectInterpret with nuclear atypia, ultrasound risk, and possible thyroiditis. ScienceDirectA Retrospective Study of Clinicopathologic Outcomes of Nodules With Hürthle Cell Cytology and the Thyroid Nodule App (TNAPP) Ultrasound Recommendations - ScienceDirect

Longitudinal Care

Match surveillance and intervention to cancer risk and patient benefit

The objective is clinically meaningful diagnosis, not maximal detection of small lesions.

For nodules that do not meet FNA criteria, continue management with the same structured ultrasound framework and reassess if the lesion crosses that system’s biopsy threshold or develops a more suspicious pattern. Avoid indiscriminate early biopsy of small lesions, because the major management problem in thyroid nodule care is overdiagnosis and excess morbidity from downstream treatment. PubMedThyroid nodule evaluation and management in older adults: A review of practical considerations for clinical endocrinologistsPubMed2023 European Thyroid Association Clinical Practice Guidelines for ...

When surgery is under consideration, incorporate suspected tumor biology, multifocality risk, local invasion, nodal disease, hereditary context, operative risk, and patient preference. Familial nonmedullary thyroid cancer has higher reported rates of multifocal disease, intraglandular dissemination, local invasion, recurrence, and lymph-node metastases, supporting early specialist involvement when a familial pattern is present. NatureFamilial thyroid cancer: a review | Modern Pathology

For an older adult with a very-low-risk tumor or a high risk of operative harm, conservative management may be a rational endpoint rather than a temporary failure to treat. State explicitly whether surveillance is intended because the lesion is below biopsy criteria, because cytology is low risk, or because treatment would not improve patient-centered outcomes. PubMedThyroid nodule evaluation and management in older adults: A review of practical considerations for clinical endocrinologists

Common questions

Should a cold thyroid nodule be biopsied if it is below the ACR TI-RADS FNA threshold?

Not routinely on the basis of cold scintigraphy alone. In a retrospective cohort, cold scintigraphy identified a small additional group with Bethesda III or higher cytology, whereas most clinically significant cytology occurred in nodules already meeting ACR TI-RADS FNA criteria. Wolters KluwerAdditional detection of Bethesda greater than or... : Nuclear Medicine Communications

Does a spongiform ultrasound pattern exclude thyroid cancer?

No. Spongiform morphology had 99.7% specificity and 98.5% negative predictive value for benign disease in cited evidence, but biopsy and follow-up decisions should still account for size criteria and clinical discordance. facs[PDF] Unexpected Diagnosis of Sporadic Medullary Thyroid Carcinoma

References

  1. Diagnosis of thyroid micronodules on ultrasound using a deep ...www.nature.com · www.nature.com
  2. Familial thyroid cancer: a review | Modern Pathologywww.nature.com · www.nature.com
  3. Elastography Enhances Diagnostic Accuracy of ACR TI-RADS in ...academic.oup.com · academic.oup.com
  4. Contemporary Thyroid Nodule Evaluation and Managementacademic.oup.com · academic.oup.com
  5. Evaluation and application of American College of Radiology ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  6. 2015 American Thyroid Association Management Guidelines for ...acsjournals.onlinelibrary.wiley.com · acsjournals.onlinelibrary.wiley.com
  7. TIRADS Management Guidelines in the Investigation of Thyroid ...academic.oup.com · academic.oup.com
  8. Preoperative diagnosis of thyroid nodules: An integrated ...acsjournals.onlinelibrary.wiley.com · acsjournals.onlinelibrary.wiley.com
  9. Consensus statement on the management of incidentally discovered ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  10. Evaluation and Management of Thyroid Nodules: A Joint Consensus ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  11. Additional detection of Bethesda greater than or... : Nuclear Medicine Communicationsjournals.lww.com · journals.lww.com
  12. Comparison of thyroid nodule FNA rates recommended by ACR TI-RADS, Kwak TI-RADS and ATA guidelineswww.sciencedirect.com · www.sciencedirect.com
  13. Clinical Outcomes of Patients With Bethesda III or IV Cytology on Fine Needle Aspiration of Thyroid Nodules—A Retrospective Study - Khan - 2025 - Endocrinology, Diabetes & Metabolism - Wiley Online Libraryonlinelibrary.wiley.com · onlinelibrary.wiley.com
  14. Thyroid Nodule Classification by Ultrasound:... : Contemporary Diagnostic Radiologyjournals.lww.com · journals.lww.com
  15. Performance of European Thyroid Imaging Reporting and Data... : Journal of Medical Ultrasoundjournals.lww.com · journals.lww.com
  16. A Retrospective Study of Clinicopathologic Outcomes of Nodules With Hürthle Cell Cytology and the Thyroid Nodule App (TNAPP) Ultrasound Recommendations - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  17. Thyroid cytology: The reality before and after the introduction of ultrasound classification systems for thyroid nodules - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  18. The Treatment of Differentiated Thyroid Cancer in Childrenacademic.oup.com · academic.oup.com
  19. Thyroid Nodule Evaluation: Us-Fna And On-Site Cytology Assessment - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  20. Thyroid nodule evaluation and management in older adults: A review of practical considerations for clinical endocrinologistspmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  21. 2023 European Thyroid Association Clinical Practice Guidelines for ...pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  22. The European Association of Nuclear Medicine (EANM)’s Response to the 2023 European Thyroid Association (ETA) clinical practice guidelines for thyroid nodule management and nuclear medicine: a deliberate oversight? - PMCpmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  23. Comparison of the C-TIRADS, ACR-TIRADS, and ATA guidelines in malignancy risk stratification of thyroid nodulespmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  24. [PDF] Unexpected Diagnosis of Sporadic Medullary Thyroid Carcinomawww.facs.org · www.facs.org